Wang Nuo
Associate Professor, Director of Institute of Optimal Allocation of Medical Resource
【Profile】
Associate Professor, Doctor of Economics, master's tutor. She is the director of Institute of Optimal Allocation of Medical Resource at School of Economics and Resource Management, BNU. She has published 2 books independently, and she also participated in the publication of 8 books, and translated 1 book. She has presided 10 research projects independently, including 6 vertical projects and 4 latitudinal projects, and co-presided 2 vertical projects. Her articles can be found in Journal of Alzheimer’s Disease 50, China Economic Report, China Journal of Chinese Materia Medica, China Population Resources and Environment.
【Publication】
【Book】
In English
1. Li, X., & Hu, B. (2011). China’s New Deal: Economic Development under International Financial Crisis. Nova Science Publishers, Inc. (Wang Nuo in charge of Chapter 9)
2. Li, X. (2013). Lectures on Macroeconomics: A Chinese Perspective. China Publishing & Media Holdings Co., Ltd. (Wang Nuo has participated)
In Chinese
1. Huang, L., Wang, N., & Yang, G. (2015). 2015-China’s Chinese Medicine Resource Development Report. Economics Science Press.(《中国中药资源发展报告2015》)
2. Wang, N. (2014). Opportunity or Challenge? The Road of China’s Active Aging. Economics Science Press.(《机遇还是挑战:中国积极老龄化道路》)
3. BNU School of Economics and Resource Management. (2012). China's Sunshine program: the world's largest project for rural transfer training. China Publishing Group & China Translation Corporation.(《中国“阳光工程”世界最大规模的农村劳动力转移培训》) (Wang Nuo in charge of Chapter 4)
4. Li, X., & Hu, B. (2012). China: Green Economy and Sustainable Development. People’s Publishing House.(《中国:绿色经济与可持续发展》)(Wang Nuo in charge of Chapter 12)
5. Li, X., & Hu, B. (2011). The New Economic Transition in China. Encyclopedia of China Publishing House.(《中国经济新转型》)(Wang Nuo in charge of Chapter 10)
6. BNU School of Economics and Resource Management. (2010). 2010 A Report on the Development of China’s Market Economy. Beijing Normal University Publishing Group.(《2010中国市场经济发展报告》)(Wang Nuo in charge of Chapter 7)
7. BNU School of Economics and Resource Management. (2010). Green Index:A State-By-State Guide to the Nations Environmental Health (Translation). Beijing Normal University Publishing Group.(《绿色指数:美国各州环境质量的评价》(译著))(Wang Nuo in charge of Chapter 6, coordinating reviewer)
8. Li, X. (2010). Lecture on Macroeconomics. China Renmin University Press.(《宏观经济学讲演录》)(Wang Nuo has participated)
【Paper】
In English
1. Wang, N. (2016). Impacts of High Serum Total Cholesterol Level on Brain Functional Connectivity in Non-Demented Elderly. Journal of Alzheimer’s Disease 50, 2016, pp.455-463.
In Chinese
1. Wang, N., Cheng, M., Zang, C., & Yang G. (2016). Discussion of price forecasting of Notoginseng Radix et Rhizoma based on ARIMA model. China Journal of Chinese Materia Medica, 41(8), pp.1559-1566.(《基于自回归积分滑动平均模型对中药材三七价格预测的讨论》)
2. Wang, N., Cheng, M., Zang, C., & Yang G. (2015). The Application of Cost-effectiveness Analysis/ Cost-benefit Analysis Method in the Research of Pollution Control of Air Particulate Matter. China Population, Resources and Environment, 2015(11), pp.85-88. (《成本-效果分析/成本-效益分析方法在雾霾治理研究中的应用》)
3. Wang, N., & Zhang, S. (2015). China’s Macroeconomic Operation and Policy Analysis.China Economic Report, 2015(11), pp.45-49. (《中国宏观经济运行及政策分析》)
4. Yang, G., Wang, N., Zhan, Z., Wang, H., & Jin, Y. (2016). Study on status of criteria for formulating specification and grade of Chinese medicinal materials based on filed survey in medicine market. China Journal of Chinese Materia Medica, 41(5), pp.761-763. (《中药材市场商品规格等级划分依据现状调查》)
5. Yang, G., Wang, N., Huang, L., Qiu, H., & Guo, L. (2014). Prudent use price controls in Chinese medicines market: based on statistical data analysis. China Journal of Chinese Materia Medica, 39(1), pp.144-148. (《中药市场应慎用“降价令”-基于统计资料的分析》)
6. Wang, N., Liu, S., & Yang, G. (2014). Exploration of influencing factors of price of herbal based on VAR model. China Journal of Chinese Materia Medica, 39(20), pp.4070-4073.(《基于向量自回归模型对我国中药材价格波动影响因素的探讨》)
7. Yang, G., Wang, N., Guo, L., Wang, Y., Huang, L., & Liu, J. (2013). Management of Chinese materia medica market based on information asymmetry. China Journal of Chinese Materia Medica, 38(23), pp.4168-4173. (《从信息不对称的角度分析《中国药典》标准管理中药的局限性》)
8. Wang, N., Zhang, Z., & Chang, D. (2012). Using Markov model to cost-effectiveness analysis of traditional Chinese medicine interference. China Journal of Chinese Materia Medica, 37(18), pp.2698-2701. (《运用Markov 模型对中药干预的成本-效果分析》)
9. Wang, N., Yang, W., & Wang, Y. (2010). New health care reform and equity in China’s health care system. Journal of Beijing University of Traditional Chinese Medicine, 33(8), pp.509-513. (《新医改与我国医疗卫生体制的公平性》)
10. Zhang, S., & Wang, N. (2014). Macroeconomic Situation and Policy Outlook. China Economic Report, 2014(6), pp.36-39. (《宏观经济形势及政策展望》)
11. Yang, G., Wang, N., Guo, L., & Huang, L. (2014). Analysis and design of signaling transfer mechanism based on third-party certification: quality prestige index of traditional Chinese medicine enterprises. China Journal of Chinese Materia Medica, 39(5), pp.925-928. (《基于TPC的中药质量信号传递机制的研究和制定--中药企业质量信誉指数和等级》)
12. Yang, G., Guo, L., Wang, N., Zeng, Y., & Huang, L. (2014). Study on supply and demand relation based on two stages division of market of Chinese materia medica. China Journal of Chinese Materia Medica, 39(2), pp.328-333. (《基于两阶段划分的中药市场供需关系研究》)
13. Xie, Y., Wang, X., Wang, N., & Chang, P. (2013). Technical specifications for post-marketing pharmacoeconomic evaluation of Chinese medicine(draft version for comments).Chinese Materia Medica, 38(18), pp.2925-2929. (《中药上市后药物经济学评价技术规范(征求意见稿)》)
【Current Research】
The economic issues on Chinese Materia Medica. (on going)